Skip to main content
Smart Investors Daily
RD

NASDAQ · RDNT

RadNet, Inc.

Healthcare · Medical - Diagnostics & Research

$69.71

Up+$0.20 (+0.29%)

Updated Nov 22, 2026, 2:17 PM

SID Score

4.2/10

Composite research score

Smart Money

58/100

Neutral

Market cap
6.07B
P/E ratio
-462.56
Dividend yield
0.00%
52-week range
$50.82 – $85.84
Volume
594.24K
Avg. volume
753.34K

Price performance · RDNT

RDNT price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Nov 20, 2026

RDNT closed at $69.71 after 20 trading sessions, down 0.49% for the selected period.

Last close
$69.71
Period change
-0.49%
Period low
$69.51
Period high
$80.26
Daily close
View OHLC price history
RDNT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 20, 2026$68.28$70.855$68.00$69.71594.24K
Nov 19, 2026$71.61$71.7575$68.55$69.51748.34K
Nov 18, 2026$74.64$76.08$71.50$71.82812.09K
Nov 17, 2026$76.24$76.59$74.77$74.92393.62K
Nov 16, 2026$77.00$77.00$75.495$76.89565.02K
Nov 13, 2026$76.49$76.98$75.06$76.42476.31K
Nov 12, 2026$78.09$78.25$75.91$76.04408.02K
Nov 11, 2026$79.03$79.96$77.83$78.08732.34K
Nov 10, 2026$80.86$80.9999$77.16$77.94661.49K
Nov 9, 2026$75.58$80.70$73.22$78.381.26M
Nov 6, 2026$77.21$78.13$72.485$76.001.66M
Nov 5, 2026$81.00$81.87$77.74$78.011.05M
Nov 4, 2026$75.32$80.57$74.35$80.261.73M
Nov 3, 2026$73.98$74.78$72.84$73.18988.53K
Nov 2, 2026$73.90$75.17$73.03$73.10960.74K
Oct 30, 2026$73.56$74.39$71.91$73.49571.7K
Oct 29, 2026$74.49$75.05$73.40$73.65472.1K
Oct 28, 2026$73.48$75.02$73.33$73.54633.16K
Oct 27, 2026$70.53$74.56$70.49$73.541.27M
Oct 26, 2026$70.58$71.77$69.76$70.05340.09K

Latest RDNT news

The latest Smart Investors Daily articles mentioning RDNT.

RDNT research

Overview

Company profile and research snapshot.

Company profile

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$88.00
Implied upside
—
Analysts
—
RDNT recent ratings
DateFirmRatingTarget
Nov 10, 2026KeybancOverweight—
Aug 28, 2026BarclaysOverweight—
Aug 11, 2026Truist SecuritiesBuy—
May 20, 2026BarclaysOverweight—
Apr 21, 2026BarclaysOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 11, 2026

RadNet (RDNT) Could Be 18% Undervalued After Its Acquisition Focus Came Into View

RadNet (RDNT) just signaled a more acquisition focused phase after its Q3 2026 update, with management highlighting a sizable cash position and plans to pursue tuck in deals across its operating segments. Recent trading reflects that shift in tone. RadNet’s share price return is up 9.9% over the past month and 9.9% year to date, while the 1 year total shareholder return is slightly down 0.7%. This is set against a very large 3 year total shareholder return of about 15x that hints at earlier...

Yahoo · Nov 11, 2026

Record Q3 Results Could Be A Big Moment For RadNet Stock (RDNT)

RadNet reported record third quarter 2026 results, with revenue of US$638.26 million, strong adjusted EBITDA, and raised full year guidance supported by advanced imaging, digital health, and new center and joint venture contributions. Management highlighted a cash balance of US$750.6 million, modest net leverage of 1.66x adjusted EBITDA, and active plans for tuck in acquisitions and efficiency focused deals such as ONRAD and other underperforming operators. We now examine how RadNet’s record...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.